Top Midday Gainers

MT Newswires Live11-13 02:52

Addex Therapeutics (ADXN) said late Wednesday its spin-out company Neurosterix closed a $105 million series B financing, valuing Addex's 8.5% stake at $18.6 million.

Shares soared 64%, with intraday trading volume catapulting to over 20.0 million from a daily average of about 140,000.

JX Luxventure (JXG) reported a 172% year-over-year surge in H1 revenue and a 75% jump in gross profit, showing that "the strategic roadmap we set in motion in 2025 is actively working and scaling our business effectively."

Shares climbed past 15%, with intraday trading volume rising to more than 27,000 from the stock's daily average of nearly 40,000.

UBS adjusted its price target for Sight Sciences (SGHT) to $13.50 from $8, while maintaining its buy rating.

Shares rose 2.3%, hitting a 52-week high, with intraday trading volume at 262,000, versus a daily average of roughly 313,000.

Price: 4.68, Change: +1.83, Percent Change: +63.96

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment